- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Vincerx Pharma (NASDAQ:VINC), Quotes and News Summary
Vincerx Pharma (NASDAQ: VINC)
Earnings
see more| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-11-11 | ||||||
| REV | |||||||
| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.880 | ||||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Vincerx Pharma Questions & Answers
You can purchase shares of Vincerx Pharma (NASDAQ: VINC) through any online brokerage.
Other companies in Vincerx Pharma’s space includes: Aeglea BioTherapeutics (NASDAQ:AGLE), Cabaletta Bio (NASDAQ:CABA), Cellectar Biosciences (NASDAQ:CLRB), Humanigen (NASDAQ:HGEN) and Galera Therapeutics (NASDAQ:GRTX).
The latest price target for Vincerx Pharma (NASDAQ: VINC) was reported by SVB Leerink on Friday, August 12, 2022. The analyst firm set a price target for 5.00 expecting VINC to rise to within 12 months (a possible 190.70% upside). 14 analyst firms have reported ratings in the last year.
The stock price for Vincerx Pharma (NASDAQ: VINC) is $1.72 last updated August 18, 2022, 8:00 PM UTC.
There are no upcoming dividends for Vincerx Pharma.
Vincerx Pharma’s Q3 earnings are confirmed for Friday, November 11, 2022.
There is no upcoming split for Vincerx Pharma.
Vincerx Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.